Showing results (51-60 of 112) with videos related to
Sort By:
Pageof 12
Journal of Advanced Research|May 31, 2024
The biomedical application of inorganic metal nanoparticles in aging and aging-associated diseasesYuqing Meng, Junzhe Zhang, Yanqing Liu, et al.Scientific Reports|February 7, 2017
Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal AxisYanqiong Zhang, Chen Yan, Yuting Li, et al.Autophagy|September 21, 2023
Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagyZhaochen Ma, Wenjia Chen, Yudong Liu, et al.Journal of Pharmaceutical and Biomedical Analysis|November 27, 2021
Integrative pharmacology powers the detection of active components and mechanism underlying Wang Bi granules in rheumatoid arthritisJia Xu, Hong Chen, Xiaofang Deng, et al.International Journal of Biological Sciences|February 13, 2023
Advanced strategies for nucleic acids and small-molecular drugs in combined anticancer therapyChong Qiu, Yanyan Wu, Qiaoli Shi, et al.Scientific Reports|October 31, 2018
Author Correction: Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validationYanqiong Zhang, Ming Bai, Bo Zhang, et al.Chinese Medicine|March 26, 2024
Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathwayTianming Lu, Lirun Zhou, Zheng Chu, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 23, 2019
Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction networkXia Mao, Haiyu Xu, Sen Li, et al.Research (Washington, D.C.)|May 30, 2023
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug DeliveryChong Qiu, Fei Xia, Junzhe Zhang, et al.Frontiers in Immunology|April 17, 2026
TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndromeQinglin Fei, Jun Chang, Tingcan Jiang, et al.Pageof 12